Democracy Spraffa

Appendix 2022-23 Priorities and Finance Planning - letter to CEs - 14 Jul 22

Argyll and Bute Council · 24 August 2022
Back to Argyll and Bute HSCP Integration Joint Board (IJB) — 24 August 2022 and its agenda

Text extracted from the council's PDF. Layout and reading order may differ from the original.

Original council PDF · Download plain text

Page 1

St Andrew’s House, Regent Road, Edinburgh  EH1 3DG
www.gov.scot

 
Health Finance, Corporate Governance &
Value Directorate
Richard McCallum, Director 
T: 0131-244 3475 
E: richard.mccallum@gov.scot 

NHS Chief Executives 
cc: 
NHS Directors of Finance
Integration Authority Chief Officers
Integration Authority Chief Finance Officers 
via email 
___ 
14th July, 2022 
Chief Executives 
2022-23 Priorities and Finance Planning 
The purpose of this letter is to confirm priorities and funding allocations for 2022-23,
reflecting discussions at the most recent Board Chief Executive meeting in June.   
Within the letter we set out: 
 The priorities for the remainder of this financial year; 
 The position regarding Agenda for Change pay and funding assumptions; and 
 The steps being taken to confirm the remaining funding allocations for 2022-23 and
expectations regarding Board’s operating within their revenue and COVID resource
limits. 
Service Priorities 
As previously set out to NHS Chief Executives, there is a considerable financial challenge in
2022-23 alongside the operational and workforce pressures that each Board is experiencing.
In view of this, consideration has been made to the areas we expect NHS Boards to prioritise
in this financial year.  These are as follows: 
 Planned Care – reduction in outpatients waiting over one year and inpatients waiting
over two years in line with our joint ambition to tackle waiting lists. The new targets
confirmed in the letter of 6 July are to eliminate: 
 two year waits for outpatients in most specialities by the end of August 2022
 18 month waits for outpatients in most specialities by the end of December 2022
 one year waits for outpatients in most specialities by the end of March 2023

Page 2

St Andrew’s House, Regent Road, Edinburgh  EH1 3DG
www.gov.scot

 
 two years waits for inpatient/daycases in the majority of specialities by September
2022
 18 month waits for inpatient/daycases in the majority of specialities by September
2023
 one year for inpatient/daycases in the majority of specialities by September 2024. 
We will confirm initial allocations in the coming weeks to support these targets and
further work will be undertaken to revisit your existing Board elective recovery plans,
following which a revised allocation will be agreed with you. 
 Cancer 31/62 day performance – we share a collective desire to enhance access to
cancer diagnosis and treatment and will work with you to agree the steps that can be
taken to improve performance, whilst acknowledging the increasing demand being
placed on all elements of the cancer pathway.   
 Unscheduled and Urgent Care – we have jointly agreed to take forward the new
Urgent and Unscheduled Care Collaborative as the means to a whole systems
approach to addressing the pressures on our unscheduled care pathways and
improving the 4 hour emergency access performance.  We will be liaising with you
and Chief Officers regarding your plans, including steps to protect elective care
capacity and address any further surges in COVID activity.  The funding to support
the unscheduled care collaborative will be in line with that announced in May, with
winter plan funding to be confirmed shortly. 
 Extended Flu and COVID vaccinations – we have been working closely with your
Delivery Lead for the Vaccination Programme and would acknowledge the significant
work that was been undertaken over the last two years and currently in preparing for
the Autumn / Winter programme.  The vaccination workforce and venue costs for
2022-23 should be met from within the COVID resource limit funding that has been
confirmed previously.  If additional surge capacity requires to be implemented to
comply with JCVI guidance, we will revisit our planning assumptions with your local
Delivery Lead. 
 Reducing Drugs Deaths – we have recently written to confirm 2022-23 funding for
ADPs and to confirm ministerial priorities, including the implementation of Joint Plans
to ensure adherence with the MAT standards.  
We acknowledge the challenges that all Boards are experiencing and the impact that this is
having on you and your staff.  We remain committed to working with you on these priorities
and supporting you and your teams to deliver the best outcomes for patients as we progress
with the recovery of the NHS.  The care and wellbeing of all our staff remains a key
consideration and it is important that any plans we agree are developed in partnership with
you. 
Agenda for Change Pay Offer 2022-23 
Financial planning until now has been based on Scottish Public Sector Pay Policy.  As the
recent Agenda for Change offer exceeds these parameters, this is an additional cost that will
need to be managed by the Portfolio.   
For planning purposes, Boards should assume that funding will be provided based on the
additional cost associated with the recent Agenda for Change offer.  Allocations will be
confirmed following conclusion of pay negotiations.

Page 3

St Andrew’s House, Regent Road, Edinburgh  EH1 3DG
www.gov.scot

 
Board Core Position and Quarter 1 Review 
The letter to Chief Executives on 1 June set out the expectations on the actions required
ahead of the formal financial Quarter 1 review.  In terms of this year, we are expecting
Boards to taking the appropriate steps to: 
 Reduce COVID expenditure in line with the resource limits that have been allocated
for 2022-23; and 
 Deliver local savings plans to ensure that you are able to achieve a position of break-
even without Scottish Government financial support by the end of the financial year. 
We acknowledge the challenge that this will present and whilst decisions should be made
locally based on the feasibility of options that you will have risk assessed, we will arrange to
discuss your Quarter 1 financial returns and Delivery Plans in further detail. 
The Directors of Finance, at their meeting on 16 June, agreed to work together with Scottish
Government to progress a number of national actions that will further assist in addressing
the financial challenge and we will keep you advised on the progress with this work. 
We have previously written to NHS Chief Executives in relation to COVID funding envelopes
for non-delegated services in the current financial year.  Work continues through the COVID
Cost Improvement Programme to address the overall scale of challenge across delegated
and non-delegated services in 2022-23 and beyond.  It remains essential that activity across
NHS Boards and Integration Authorities is fully aligned with this work and that costs are
minimised as far possible. 
As you will be aware, we do not anticipate any further COVID consequentials in 2022-23 or
in future years.  Therefore any recurring costs will be met through confirmed recurring
allocations (e.g. sustainable vaccination workforce) or from existing baseline budgets.  To
manage this pressure moving forward, Boards should actively be developing local COVID
exit plans alongside the work of the national COVID Cost Improvement Programme. 
As previously confirmed, Boards will be provided with funding to meet the costs of delivery of
the Test and Protect programme and you are not expected to cover these within your COVID
resource allocation. 
2022-23 Funding 
As colleagues will be aware, work continues on addressing the significant financial challenge
across the Health and Social Care portfolio this financial year.  As work continues across the
Scottish Government’s Health and Social Care Directorates, it is important that a consistent
and prudent approach is taken regarding funding expectations. 
For planning purposes, Boards and Integration Authorities should assume funding broadly in
line with levels received in 2021-22, except where separate approval or confirmation has
been provided by the relevant SG policy teams.  Further clarity on the funding position will be
provided to NHS Directors of Finance and IA Chief Finance Officers in the coming weeks. 
For ring-fenced amounts carried forward by Integration Authorities, it remains our general
expectation that these are utilised in full before further funding is provided by Scottish
Government.

Page 4

St Andrew’s House, Regent Road, Edinburgh  EH1 3DG
www.gov.scot

 
2023-24 and beyond 
In terms of the approach for 2023-24 and beyond, we are progressing the planning which will
bring together the key priorities for future service delivery, in the context of the medium term
financial framework and workforce plan.  Given the anticipated challenges over the Spending
Review period as recently set out by the Cabinet Secretary for Finance and Economy, it is
important that we engage with you on the planning scenarios and options that we may need
to consider in terms of both recovery and future reform, including planning for a new National
Care Service. 
We would thank you for your support at this time and we will continue to work closely with
you in taking forward the priorities for this financial year. 
Yours sincerely 
John Burns
Chief Operating Officer – NHS Scotland 
Richard McCallum
Director of Health Finance and Governance